- Fund Type: Fund of Funds
- Objective: Flexible Portfolio
- Asset Class: Asset Allocation
- Geographic Focus: U.S.
Callan Glidepath 2040 Fund
+ Add to WatchlistCG4070U:US
12.03 USD 0.02 0.17%As of 19:25:18 ET on 05/21/2013.
Snapshot for Callan Glidepath 2040 Fund (CG4070U)
| Year To Date: | +14.68% | 3-Month: | +9.96% | 3-Year: | - | 52-Week Range: | 9.02 - 12.03 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +7.41% | 1-Year: | +29.22% | 5-Year: | - | Beta vs SPX: | - |
Fund Profile & Information for CG4070U
The Callan GlidePath 2040 Fund seeks to achieve long-term capital growth by investing in a diversified mix of asset classes and investment styles which become increasingly conservative over time. The asset allocation for the Fund is designed for participants of qualified retirement plans that intend to retire within five years of the year 2040.
| Inception Date: | 02-02-2012 | Telephone: | 1-415-974-5060 Tel |
|---|---|---|---|
| Managers: | KELLY CLIFF | ||
| Web Site: | www.callan.com | ||
Fundamentals for CG4070U
| NAV | (on 2013-05-21) 12.03 |
|---|---|
| Assets (M) | (on 2013-05-21) 19.54 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for CG4070U
No dividends reported
Fees & Expenses for CG4070U
| Front Load | - |
|---|---|
| Back Load | - |
| Current Mgmt Fee | - |
| Redemption Fee | - |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for CG4070U
Filing Date: 07/31/2012| Name | Position | Value | % of Total |
|---|---|---|---|
| Guardian Capital Group Ltd | 169,930 | 1,328,852 | 9.522% |
| SSgA MSCI EAFE Index Fund | 74,695 | 1,316,058 | 9.430% |
| Dodge & Cox International Stoc | 42,979 | 1,307,422 | 9.368% |
| PIMCO Small Cap StocksPlus AR | 135,077 | 1,044,141 | 7.482% |
| Royce Pennsylvania Mutual Fund | 92,747 | 1,033,204 | 7.404% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page